Transplanted intrahepatic islets: Enigmatic absence of the α-cell response to hypoglycaemia

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 6, 2002, Pages 433-437

  Robertson, R P ^a  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Alpha cell; Hypoglycaemia; Islet transplantation

Indexed keywords

GLUCAGON; GLUCOCORTICOID; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; POLYPEPTIDE; TOXIC SUBSTANCE;

ADRENERGIC NERVE; AUTOIMMUNE DISEASE; CELL DAMAGE; CELL FUNCTION; CELL ISOLATION; CENTRAL NERVOUS SYSTEM; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INNERVATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SYNTHESIS; LIVER CELL DAMAGE; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PEPTIDE SYNTHESIS; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMANS; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; PANCREATIC POLYPEPTIDE;

EID: 0036966548     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., Kneteman N.M., Rajotte R.V.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [see comments]. N. Engl. J. Med. 343: 230-238, 2000.
2. Ryan E.A., Lakey J.R., Rajotte R.V., Korbutt G.S., Kin T., Imes S., Rabinovitch A., Elliott J.F., Bigam D., Kneteman N.M., Warnock G.L., Larsen I., Shapiro A.M.: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710-719, 2001.
3. Pyzdrowski K.L., Kendall D.M., Halter J.B., Nakhleh R.E., Sutherland D.E., Robertson R.P.: Preserved insulin secretion and insulin independence in recipients of islet autografts [see comments]. N. Engl. J. Med. 327: 220-226, 1992.
4. Kendall D.M., Teuscher A.U., Robertson R.P.: Defective glucagon secretion during sustained hypoglycaemia following successful islet allo- and autotransplantation in humans. Diabetes 46: 23-27, 1997.
5. Yale J.F., Roy R.D., Grose M., Seemayer T.A., Murphy G.F., Marliss E.B.: Effects of cyclosporine on glucose tolerance in the rat. Diabetes 34: 1309-1313, 1985.
6. Robertson R.P.: Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 35: 1016-1019, 1986.
7. Odocha O., McCauley J., Scantlebury V., Shapiro R., Carroll P., Jordan M., Vivas C., Fung J.J., Starzl T.E.: Post-transplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant. Proc. 25: 2433-2434, 1993.
8. Herold K.C., Nagamatsu S., Buse J.B., Kulsakdinun P., Steiner D.F.: Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation 55: 186-192, 1993.
9. Tamura K., Fujimura T., Tsutsumi T., Nakamura K., Ogawa T., Atumaru C., Hirano Y., Ohara K., Ohtsuka K., Shimomura K.: Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 59: 1606-1613, 1995.
10. Redmon J.B., Olson L.K., Armstrong M.B., Greene M.J., Robertson R.P.: Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J. Clin. Invest. 98: 2786-2793, 1996
11. Delaunay F., Khan A., Cintra A., Davani B., Ling Z.C., Andersson A., Ostenson C.G., Gustafsson J., Efendic S., Okret S.: Pancreatic β-cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 100: 2094-2098, 1997.
12. Drachenberg C.B., Klassen D.K., Weir M.R., Wiland A., Fink J.C., Bartlett S.T., Cangro C.B., Blahut S., Papadimitriou J.C.: Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68: 396-402, 1999,
13. Gupta V., Wahoff D.C., Rooney D.P., Poitout V., Sutherland D.E., Kendall D.M., Robertson R.P.: The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycaemia is transplantation site-determined. Diabetes 46: 28-33, 1997.
14. Sibley R.K., Sutherland D.E., Goetz F., Michael A.F.: Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53: 132-144, 1985.
15. Biggers D.W., Myers S.R., Neal D., Stinson R., Cooper N.B., Jaspan J.B., Williams P.E., Cherrington A.D., Frizzell R.T.: Role of brain in counterregulation of insulin-induced hypoglycaemia in dogs. Diabetes 38: 7-16, 1989.
16. Havel P.J., Taborsky G.J., Jr.: The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycaemic stress. Endocr. Rev. 10: 332-350, 1989.
17. Diem P., Redmon J.B., Abid M., Moran A., Sutherland D.E., Halter J.B., Robertson R.P.: Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J. Clin. Invest. 86: 2008-2013, 1990
18. Moran A., Diem P., Klein D.J., Levitt M.D., Robertson R.P.: Pancreatic endocrine function in cystic fibrosis. J. Pediatr. 118: 715-723, 1991.